Lupin Gets USFDA Nod For Generic Cancer Treatment Drug Kajal Rajput30 Aug 2022 1:29 PM ISTMumbai: Global pharma major Lupin Limited (Lupin) in partnership with Pharmascience Inc. today announced that it has received tentative approval from...
Lupin rolls out Desvenlafaxine ER tablets in US Ruchika Sharma27 Aug 2022 9:30 AM ISTMumbai: Global pharma major, Lupin Limited, has announced the launch of Desvenlafaxine Extended-Release Tablets, 25 mg, having received an approval...
Lupin arm bags UK MHRA nod for COPD treatment Lutio Ruchika Sharma26 Aug 2022 1:25 PM ISTThe product is a generic version of Spiriva.
Lupin to acquire diabetes brands Ondero, Ondero-Met from Boehringer Ingelheim for Rs 207 crore Ruchika Sharma25 Aug 2022 3:30 PM ISTNew Delhi: Lupin Limited is soon going to acquire two diabetes brands Ondero and Ondero - Met from Boehringer Ingelheim International GmbH for Rs...
Lupin, I'rom ink pact for biosimilar Denosumab Ruchika Sharma25 Aug 2022 12:30 PM ISTCurrently, Denosumab is available under two brands, Pralia and Ranmark.
Lupin gets USFDA nod for generic equivalent of Mylan Specialty Perforomist Inhalation Solution Ruchika Sharma24 Aug 2022 5:00 PM ISTPERFOROMIST Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist)
Lupin bags USFDA okay for seizure treatment drug Rufinamide Ruchika Sharma18 Aug 2022 3:23 PM ISTRufinamide Tablets will be manufactured at Lupin’s facility in Goa, India.
Lupin rationalising product portfolio in US to overcome price erosion impact, says CEO Vinita Gupta Ruchika Sharma16 Aug 2022 1:30 PM ISTLupin's transitioning of the portfolio from the simple generic oral solids to complex generics had started with short-acting bronchodilator albuterol.
Lupin bags USFDA nod for Meclizine Hydrochloride Tablets Ruchika Sharma13 Aug 2022 1:00 PM ISTThe product is a generic equivalent of Antivert Tablets, 12.5 mg, 25 mg, and 50 mg, of Casper Pharma LLC.
Lupin secures USFDA nod for Azilsartan Medoxomil Tablets Ruchika Sharma25 July 2022 5:46 PM ISTThe product will be manufactured at Lupin’s facility in Nagpur, India.
Lupin Diagnostics unveils Reference Laboratory in Ranchi Ruchika Sharma19 July 2022 4:15 PM ISTRanchi: Global pharma major Lupin Limited announced today that Lupin Diagnostics has launched its first Reference Laboratory in Ranchi. The new...
CDSCO Panel rejects Lupin FDC of Tranexamic Acid and Mefenamic Acid Dr. Divya Colin11 July 2022 6:00 PM ISTNew Delhi: Rejecting the proposal presented by pharmaceutical major Lupin, the Subject Expert Committee (SEC) functional under Central Drug Standard...
